Clinical Comparison of Two Silicone-Hydrogel Contact Lenses

June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
The objective of this study is to evaluate the clinical performance of two silicone-hydrogel contact lenses.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

97

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The subject must be at least 18 and less than or equal to 39 years of age and have a need for vision correction in both eyes.
  • The subject must require a lens power between -1.00 to -6.00D and have no more than 1.00D of corneal cylinder.
  • The subject, based on his/her knowledge, must be in good general health.
  • The subject must be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluations.
  • Subject must be a current adapted daily wearer of soft contact lenses with at least 6 months of CL wear.
  • Subject must agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  • Subject must be willing and able to use only the care systems and lubricating drops provided for the study during the 4 week period.
  • The subject must read, indicate understanding of and sign the Informed Consent Form.

Exclusion Criteria:

  • The subject is a rigid gas permeable (RGP) or daily disposable lens wearer.
  • The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids or associated structures.
  • The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjogren's syndrome, type II diabetes, etc.)
  • Slit lamp findings that would contraindicate contact lens wear such as:

    • pathological dry eye or associated findings
    • pterygium or corneal scars within the visual axis
    • neovascularization equal to or greater than 1mm in from the limbus
    • history of giant papillary conjunctivitis (GPC) worse than grade 2
    • anterior uveitis or iritis (past or present)
    • seborrhoeic eczema
    • seborrhoeic conjunctivitis
  • A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
  • A known history of corneal hypoesthesia (reduced corneal sensitivity).
  • Contact lens snellen visual acuities (VA) worse than 20/30.
  • Aphakia, keratoconus or a highly irregular cornea.
  • Current pregnancy or lactation (to the best of the subject's knowledge)
  • Any active participation in another clinical study at any time during this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: galyfilcon A/comfilcon A
galyfilcon A first, comfilcon A second
galyfilcon A
comfilcon A
Active Comparator: comfilcon A/galyfilcon A
comfilcon A first, galyfilcon A second
galyfilcon A
comfilcon A

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Comfort
Time Frame: 1-week, 2- weeks
>0 = comfortable, <0 = uncomfortable; a weighted combined score calculated from individual comfort-related questions was used to derive comfort outcomes.
1-week, 2- weeks
Comfort Symptoms
Time Frame: 1-week, 2-weeks
A weighted combined score calculated from individual comfort-related questions was used to derive comfort outcomes. >0 = comfortable, <0 = uncomfortable
1-week, 2-weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Corneal Staining
Time Frame: 2 weeks
Measured for 5 zones of the cornea (superior, nasal, central, inferior, temporal)on a 0 to 3 grade scale (NEI 0-3 scale). Grade 0 = Normal/ grade 1 = mild, superficial stippling/ grade 2 = moderate, punctate staining including superficial abrasion of the cornea/ grade 3 = severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

October 1, 2007

Study Completion (Actual)

October 1, 2007

Study Registration Dates

First Submitted

September 29, 2008

First Submitted That Met QC Criteria

September 29, 2008

First Posted (Estimate)

September 30, 2008

Study Record Updates

Last Update Posted (Actual)

June 19, 2018

Last Update Submitted That Met QC Criteria

June 18, 2018

Last Verified

May 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CR-0713

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Error

Clinical Trials on galyfilcon A

3
Subscribe